Checkpoint inhibitor-associated drug reaction with eosinophilia and systemic symptom syndrome
The DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
Drug reaction with eosinophilia and systemic symptom syndrome is a potentially fatal drug reaction that must be recognized quickly. Ipilimumab and nivolumab are both important agents in the treatment of melanoma and continue to be studied in other malignancies. We believe the mainstay of therapy for immunotherapy-induced drug reaction with eosinophilia and systemic symptom syndrome is early recognition, discontinuation of the inciting agent, supportive care, and treatment with high dose corticosteroids with appropriate tapers that may reduce the length of internal organ injury in cases with liver or kidney involvement.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Even if some severe cutaneous AEs like drug reaction with eosinophilia and systemic symptoms (DRESS) require high-dose corticosteroids,25,26”
Citations
The citation lists are queued
They are fetched later and appear here then.
References 22 · Cited by 58
Metadata
- Authors
- Mirza, S., Hill, E., Ludlow, S. P., & Nanjappa, S.
- Affiliations
- Department of Internal Medicine, University of South Florida, Tampa, Florida, USA
- Moffitt Cancer Center (US)
- Corresponding author
- Ludlow, Steven P.
- ORCID
- Nanjappa, Sowmya
- Venue
- Melanoma Research
- Published
- 2017-06
- Volume
- 27
- Issue
- 3
- Pages
- 271-273
- ISSN
- 0960-8931 (ISSN-L)
- OpenAlex
- W2586640730
- Semantic Scholar
- 4e1c4feb50d5de9a03ee3eed47b41d6cd3b081d3
- Cited by
- 58
- References
- 22
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 8 · 2023: 7 · 2022: 5 · 2021: 11 · 2020: 7 · 2019: 7 · 2018: 4 · 2017: 1
- FWCI
- 2.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Melanoma Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- DRESS syndrome, immune checkpoint inhibitors, ipilimumab, nivolumab, melanoma, immunotherapy adverse events, corticosteroid therapy, drug discontinuation, liver injury, kidney injury
- MeSH terms
- Antineoplastic Agents, Immunological, Ipilimumab, Nivolumab, Adrenal Cortex Hormones, Antibodies, Monoclonal, Eosinophilia, Humans, Immunotherapy, Male, Melanoma, Middle Aged, Prognosis, Cell Cycle Checkpoints, Drug Hypersensitivity Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Checkpoint inhibitor-associated drug reaction with eosinophilia and systemic symptom syndrome. https://app.cochat.ai/papers/10.1097/cmr.0000000000000326
- The paper
- Mirza, S., Hill, E., Ludlow, S. P., & Nanjappa, S. (2017). Checkpoint inhibitor-associated drug reaction with eosinophilia and systemic symptom syndrome. Melanoma Research. https://doi.org/10.1097/cmr.0000000000000326
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.